Zobrazeno 1 - 10
of 319
pro vyhledávání: '"chronic thromboembolic pulmonary hypertension (CTEPH)"'
Autor:
Beatrice Simeone, Enrico Maggio, Leonardo Schirone, Erica Rocco, Gianmarco Sarto, Luigi Spadafora, Marco Bernardi, Luca D’ Ambrosio, Maurizio Forte, Daniele Vecchio, Valentina Valenti, Sebastiano Sciarretta, Carmine Dario Vizza
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) presents a significant diagnostic challenge due to its complex and often nonspecific clinical manifestations. This review outlines a comprehensive approach to the diagnostic assessment of CTEPH, e
Externí odkaz:
https://doaj.org/article/8636b5108e1d485fa2e0897feadf7467
Autor:
Beatrice Simeone, Enrico Maggio, Leonardo Schirone, Erica Rocco, Gianmarco Sarto, Luigi Spadafora, Marco Bernardi, Luca D’Ambrosio, Maurizio Forte, Daniele Vecchio, Valentina Valenti, Sebastiano Sciarretta, Carmine Dario Vizza
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.
Externí odkaz:
https://doaj.org/article/a178a3f6d8e54855976749e0dadffd24
Publikováno v:
Life, Vol 14, Iss 10, p 1265 (2024)
Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased pulmonary vascular resistance and remodeling, often precipitating right-sided heart dysfunction and death. Although the condition is progressive and incurable, cur
Externí odkaz:
https://doaj.org/article/d91b094975094067a1685931e192ab6a
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
BackgroundNew-onset postoperative atrial fibrillation (POAF) is a common complication after pulmonary thromboendarterectomy (PEA), yet the risk factors and their impact on prognosis remain poorly understood. This study aims to investigate the risk fa
Externí odkaz:
https://doaj.org/article/0259460a559141c79854e3dc244f91af
Autor:
Lojain Abdulaal, Ahmed Maiter, Mahan Salehi, Michael Sharkey, Turki Alnasser, Pankaj Garg, Smitha Rajaram, Catherine Hill, Christopher Johns, Alex Matthew Knox Rothman, Krit Dwivedi, David G. Kiely, Samer Alabed, Andrew James Swift
Publikováno v:
Frontiers in Radiology, Vol 4 (2024)
BackgroundChronic pulmonary embolism (PE) may result in pulmonary hypertension (CTEPH). Automated CT pulmonary angiography (CTPA) interpretation using artificial intelligence (AI) tools has the potential for improving diagnostic accuracy, reducing de
Externí odkaz:
https://doaj.org/article/b535f80e113f4662891fd5d96333ce2f
Publikováno v:
JA Clinical Reports, Vol 9, Iss 1, Pp 1-4 (2023)
Abstract Background Pulmonary endarterectomy (PEA) is a treatment modality for chronic thromboembolic pulmonary hypertension (CTEPH). PEA requires anesthesia management to prevent an increase in pulmonary vascular resistance (PVR) and circulatory fai
Externí odkaz:
https://doaj.org/article/42277dce1e0946feac5f6ffa5855dcda
Autor:
Louise C. Kirkby, Matthew S. Rodgers, Liliana Amaral‐Almeida, Karen Sheares, Mark Toshner, Katherine Bunclark, Aleksandra Bartnik, Dolores Taboada, Choo Ng, Fouad J. Taghavi, Steven Tsui, John E. Cannon, Jonathan R. Weir‐McCall, John G. Coghlan, David P. Jenkins, Joanna Pepke‐Zaba, Stephen P. Hoole
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)
Abstract Pulmonary endarterectomy (PEA) may not achieve full clearance of vascular obstructions in patients with more distal chronic thromboembolic pulmonary hypertension (CTEPH). Balloon pulmonary angioplasty (BPA) may be indicated to treat these re
Externí odkaz:
https://doaj.org/article/dabd800258ff4bfdb17ac8fc534df12c
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Chronic thromboembolic pulmonary hypertension (CTEPH) is a challenging diagnosis that can occur even in the absence of a prior thrombotic event. The main screening test is ventilation-perfusion (VQ) scintigraphy. The gold standard treatment for CTEPH
Externí odkaz:
https://doaj.org/article/099404203ea04e3dbcfc59bade7cabaa
Autor:
Lars T. Nilsson, Therese Andersson, Flemming Larsen, Irene M. Lang, Per Liv, Stefan Söderberg
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-9 (2021)
Dyspnea is common after a pulmonary embolism. Often, but not always, the dyspnea can be explained by pre‐existing comorbidities, and only rarely by chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is probably the extreme manifestation o
Externí odkaz:
https://doaj.org/article/6d2741ade8f14299847235278204be2e
Autor:
Jixiang Liu, Ziyi Chang, Zhu Zhang, Bei Wang, Wanmu Xie, Qian Gao, Shuai Zhang, Yunxia Zhang, Han Tian, Zhihui Fu, Yishan Li, Kaiyuan Zhen, Shuangshuang Ma, Dingrong Zhong, Peiran Yang, Zhenguo Zhai
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundChronic thromboembolic pulmonary hypertension (CTEPH) patients may present with atherosclerotic lesions in their pulmonary arteries, but their clinical characteristics remain unclear. The metabolic pathways associated with the atherosclerot
Externí odkaz:
https://doaj.org/article/5c5f8bd2a1944208af9ac1fbfaf378df